News
Latest News, Announcements, and Press Releases
29May 18
Codexis to Present at Three Upcoming Investment Conferences
REDWOOD CITY, Calif. , May 29, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at three upcoming investment conferences: 15 th Annual Craig-Hallum Institutional Investor Conference on Wednesday, May 30 ,…
read more10May 18
Codexis Reports First Quarter 2018 Financial Results
Total revenues increase 76% to $14.0 million on sharply higher R&D revenue Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif. , May 10, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces…
read more03May 18
Codexis to Hold First Quarter 2018 Conference Call on May 10
REDWOOD CITY, Calif. , May 03, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report first quarter 2018 financial results after market close on Thursday, May 10, 2018 . Codexis management will…
read more23Apr 18
Porton Pharma Solutions and Codexis Launch Global Partnership
View translation: Japanese | Simplified Chinese | Traditional Chinese Redwood City, Calif., and Chongqing, China (April 23, 2018) – Codexis, Inc. (NASDAQ: CDXS) and Porton Pharma Solutions, Ltd. (SZSE: 300363) announce a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology…
read more23Apr 18
Porton Pharma Solutions and Codexis Launch Global Partnership
REDWOOD CITY, Calif. & CHONGQING, China –(BUSINESS WIRE)–Apr. 23, 2018– Codexis, Inc. (NASDAQ: CDXS) and Porton Pharma Solutions, Ltd. (SZSE: 300363) announce a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology within Porton’s global custom intermediate and active
read more05Apr 18
Codexis Announces Pricing of Public Offering of Common Stock
REDWOOD CITY, Calif. , April 05, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced the pricing of an underwritten public offering of 3,750,000 shares of its common stock at a public offering price of $9.25…
read more05Apr 18
Codexis Announces Proposed Public Offering of Common Stock
REDWOOD CITY, Calif. , April 05, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares to be…
read more05Apr 18
Codexis to Present at H.C. Wainwright Global Life Sciences Conference in Monte Carlo, Monaco
REDWOOD CITY, Calif. , April 05, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at the H.C. Wainwright Global Life Sciences Conference on Tuesday, April 10, 2018 at 9:50 a.m. Central…
read more08Mar 18
Codexis Reports 2017 Fourth Quarter and Full Year Financial Results
2017 revenues of $50 million include a 74% increase in product sales Introduces 2018 financial guidance Conference call begins at 4:30 pm Eastern time today Accompanying slide presentation available on Investor section of company website REDWOOD CITY, Calif.
read more01Mar 18
Codexis to Hold 2017 Fourth Quarter and Full Year Conference Call on March 8
REDWOOD CITY, Calif. , March 01, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report fourth quarter and full year 2017 financial results after market close on Thursday, March 8, 2018 .
read moreSince 2002, Codexis has created new technologies to unlock the power of proteins™. Put our unmatched protein engineering expertise to work for you.
Unlock the power of proteins™ with Codexis
Learn More
Company
Industries